epicatechin 3-O-(3'-O-methylgallate)

A gallate ester obtained by formal condensation of the carboxy group of gallic acid with the (3R)-hydroxy group of epicatechin.


gallate ester

A benzoate ester that is any ester resulting from the formal condensation of the carboxy group of gallic acid (3,4,5-trihydroxybenzoic acid) with an alcoholic or phenolic hydroxy group.


A gallate ester obtained by formal condensation of the carboxy group of gallic acid with the (3S)-hydroxy group of (+)-epicatechin.


A benzenetriol that is benzophenone in which one of the phenyl groups is substituted at by hydroxy groups at positions 2, 4, and 6.


CATECHIN GALLATE

A gallate ester obtained by formal condensation of the carboxy group of gallic acid with the (3S)-hydroxy group of (+)-catechin.


A benzenetriol that is benzene-1,2,4-triol substituted by a (8Z)-pentadec-8-en-1-yl group at position 6.


THEASINENSIN A

A biflavonoid that is obtained by coupling of two molecules of (-)-epigallocatechin 3-gallate resulting in a bond between positions C-2 of the hydroxyphenyl ring. It is a natural product found in oolong tea.


A butan-4-olide that is gamma-valerolactone in which one of the methyl hydrogens has been replaced by a 3,4,5-trihydroxyphenyl group.


A 2-acylphloroglucinol in which the acyl group is specified as hexanoyl. It is the intermediate biosynthetic precursor for differentiation-inducing factor 1 (DIF-1).


A galloyl-beta-D-glucose compound having four galloyl groups in the 1-, 2-, 3- and 6-positions.


DEMETHYLXANTHOHUMOL

A member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 4, 2', 4', and 6'  and a 3-methylbut-2-en-1-yl group at position 3'.


multifidol

A butanone that is the 2-methylbutanoyl derivative of phloroglucinol.


macabarterin

A ellagitannin isolated  from the stem bark of Macaranga barteri and has been shown to exhibit anti-inflammatory activity.


procyanidin B1 3-O-gallate

A gallate ester obtained by formal condensation of the carboxy group of gallic acid with the (3R)-hydroxy group of procyanidin B1.


procyanidin B2 3-O-gallate

A gallate ester obtained by formal condensation of the carboxy group of gallic acid with the (3R)-hydroxy group of procyanidin B2.


A galloyl-beta-D-glucose compound having two galloyl groups in the 1- and 6-positions.


A gallate ester obtained by formal condensation of the carboxy group of gallic acid with the (3'R)-hydroxy group of (-)-epicatechin-(4alpha->8)-(-)-epicatechin.


A gallate ester resulting from the formal condensation of gallic acid with 5-hydroxy group of (-)-epicatechin. Isolated from Orostachys japonica, it acts as an inhibitor of the enzyme mu-calpain (EC 3.4.22.52).


A benzenetriol that is benzene-1,2,4-triol substituted by a pentadecyl group at position 6.


A 2-acylphloroglucinol in which the acyl group is specified as 2-methylbutanoyl.


An aromatic ketone that is prenylphloroglucinol in which one of the two ring hydrogens has been replaced by an acyl group.


homoeriodictyol chalcone

A member of the class of  chalcones that is  trans-chalcone substituted by hydroxy groups at positions 4, 2', 4' and 6' and a methoxy group at position 3.


deoxyadlupulone

A 2-acyl-4,6-diprenylphloroglucinol in which the acyl group is specified as 2-methylbutanoyl.


A 6-deoxyaltrose that is beta-D-altrofuranose in which the hydroxy group at position 6 has been replaced by a hydrogen.


Any  deoxyaltrose in which the hydroxy group at position 6 has been replaced by a hydrogen.


12,13-dihydroxyfumitremorgin C

An indole alkaloid  that is fumitremorgin C substituted at positions 12 and 13 by hydroxy groups.


name: multiple congenital anomalies-hypotonia-seizures syndrome

category: biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing


name: developmental and epileptic encephalopathy, 77


name: multiple congenital anomalies-hypotonia-seizures syndrome 3

description: A rare congenital disorder of glycosylation characterized by neonatal hypotonia, global development delay, developmental regress and severe to profound intellectual disability, infantile onset seizures that are initially associated with febrile episodes with subsequent transition to unprovoked seizures, impaired vision with esotropia and nystagmus, progressive cerebral and cerebellar atrophy, skeletal abnormalities (including brachycephaly, scoliosis, slender long bones, delayed bone age, pectus excavatum and osteopenia), inverted nipples and dysmorphic features including high and narrow forehead, frontal bossing, short nose, depressed nasal bridge, anteverted nares, high palate and wide open mouth consistent with facial hypotonia. Other features may include cardiac abnormalities (such as patent ductus arteriosus, atrial septal defects), urogenital abnormalities (such as nephrocalcinosis, urolithiasis), and low plasma concentration of alkaline phosphatase.


name: multiple congenital anomalies-hypotonia-seizures syndrome 2

description: Any multiple congenital anomalies/dysmorphic syndrome-intellectual disability in which the cause of the disease is a mutation in the PIGA gene.


LAMINARIPENTAOSE

A (1->3)-beta-D-glucan consisting of five D-glucosyl residues linked in a linear sequence.


apigenin 7-O-beta-L-glucoside

A glycosyloxyflavone that is apigenin substituted by a beta-L-glucopyranosyl moiety at position 7 via a glycosidic linkage.


A glycotetraosylceramide having beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucose as the tetrasaccharide component.


Cranial Nerve II Palsy

description: Partial or complete paralysis of the optic nerve.


Non-Neoplastic Optic Nerve Disorder

description: A non-neoplastic disorder that affects the optic nerve.


Unilateral Optic Nerve Hypoplasia

description: A congenital abnormality characterized by the underdevelopment of one optic nerve.


sulfoglycochenodeoxycholic acid

A steroid sulfate that is the 3-O-sulfo derivative of glycochenodeoxycholic acid.


steroid sulfate

A sulfuric ester obtained by the formal condensation of a hydroxy group of any steroid with sulfuric acid.


clathsterol disulfonic acid

A steroid sulfate which is 16-hydroxystigmastane-2,3-diyl disulfonic acid that is substituted by a acetyloxy group at position 15 and by butanoyloxy groups at positions 22 and 23.


HALISTANOL SULFATE G

A steroid sulfate that is 5alpha-ergostane substituted by sulfate groups at positions 2, 3 and 6 (the (2beta,3alpha,6alpha stereoisomer).


2-hydroxy-17beta-estradiol 3-sulfate

A steroid sulfate that is 2-hydroxy-17beta-estradiol in which the phenolic hydrogen at position 3 has been replaced by a sulfo group.


21-hydroxypregnenolone disulfate

A steroid sulfate that is 21-hydroxypregnenolone in which both hydroxy hydrogens have been replaced by sulfo groups.


A steroid sulfate that is 5alpha-pregnane-3beta,20alpha-diol in which both hydroxy hydrogens have been replaced by sulfo groups.


name: sulfuric acid [(8R,9R,13S,14R)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] ester


testosterone sulfate

A steroid sulfate that is testosterone substituted by a sulfoxy group at position 17.


(24S)-hydroxycholesterol 24-sulfate

A steroid sulfate that is (24S)-24-hydroxycholesterol carrying a single sulfo substituent at the O-24 position.


17beta-estradiol 3-sulfate

A steroid sulfate obtained by the formal condensation of sulfuric acid with the 3-hydroxy group of 17beta-estradiol.


A withanolide that is 2,3-dihydrowithaferin A substituted by a sulfoxy group at position 3. Isolated from Physalis longifolia, it exhibits antineoplastic activity.


androsterone sulfate

A steroid sulfate that is the 3-sulfate of androsterone.


(24S)-hydroxycholesterol 3-sulfate

A steroid sulfate that is (24S)-24-hydroxycholesterol carrying a single sulfo substituent at the O-3 position.


halistanol sulfonic acid F

A steroid sulfate with anti-HIV activity.


17alpha-ethynylestradiol 3-sulfate

A steroid sulfate that is 17alpha-ethynylestradiol in which the phenolic hydrogen at position 3 has been replaced by a sulfo group.


epiandrosterone sulfate

A steroid sulfate that is the 3-sulfate of epiandrosterone.


5beta-cyprinol sulfate

A steroid sulfate that is the sulfuric ester derivative of 5beta-cyprinol.


cortisol 21-sulfate

A steroid sulfate obtained by the formal condensation of hydroxy group at position 21 of cortisol with sulfuric acid.


A brassinosteroid that is 24-epi-cathasterone on which the hydroxy hydrogen at position 22 has been replaced by a sulfo group.


glycodeoxycholic acid 3-sulfate

A bile acid glycine conjugate that is glycodeoxycholic acid in which the hydroxy hydrogen at position 3 has been replaced by a sulfo group.


5alpha-dihydrotestosterone sulfate

A 3-oxo-5alpha-steroid that is 5alpha-dihydrotestosterone in which the hydroxy hydrogen at position 17 has been replaced by a sulfo group.


17beta-estradiol 17-sulfate

A steroid sulfate obtained by the formal condensation of sulfuric acid with the 17-hydroxy group of 17beta-estradiol.


WITHALONGOLIDE G

A  withanolide that is 2,3-dihydrowithaferin A substituted by a hydroxy group at position 19 and a sulfoxy group at position 3. Isolated from Physalis longifolia, it exhibits antineoplastic activity.


5alpha-pregnane-3,20beta-diol disulfate

A steroid sulfate that is 5alpha-pregnane-3,20beta-diol in which both hydroxy hydrogens have been replaced by sulfo groups.


(24S)-hydroxycholesterol 3,24-disulfate

A steroid sulfate that is (24S)-24-hydroxycholesterol in which both hydroxy hydrogens have been replaced by sulfo groups.


cholesterol sulphate

A steroid sulfate that is cholesterol substituted by a sulfoxy group at position 3.


name: sulfuric acid [(13S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] ester


17alpha-hydroxypregnenolone 3-sulfate

A steroid sulfate that is 17alpha-hydroxypregnenolone in which the hydroxy hydrogen at position 3 has been replaced by a sulfo group.


A steroid sulfate that is 4-androstene-3beta,17beta-diol in which both hydroxy hydrogens have been replaced by sulfo groups.


lithocholic acid sulfate

A steroid sulfate that is lithocholic acid in which the hydroxy hydrogen at position 3 has been replaced by a sulfo group.


name: IWG-MRT Myelodysplastic Syndrome Minor Hematologic Improvement-Erythroid Response in High Transfusion Burden

category: biolink:PhenotypicFeature biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: Minor hematologic improvement-erythroid response in high transfusion burden patients is defined as a reduction by at least 50% of RBCs over a minimum of 8 weeks with the same transfusion policy (defined in "1.2.4. Transfusion policy") compared with 16 weeks prior to treatment. Only a response duration of at least 16 weeks, however, is considered clinically meaningful. (Adapted from Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials; Blood 2019 133: 1020-1030)


cyanate ester

Esters of cyanic acid, HOC#N.


cataract 33

description: Any early-onset non-syndromic cataract in which the cause of the disease is a mutation in the BFSP1 gene.


name: immunodeficiency, developmental delay, and hypohomocysteinemia


name: Grade 1 Pelvic Muscle Weakness Not Due to Neuropathy, CTCAE


name: Generalized or Specific Area Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 4 Whole Body and Generalized Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 5 Trunk Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 1 Lower Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


name: Right-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 4 Right-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 4 Left-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 5 Upper Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 3 Whole Body and Generalized Muscle Weakness Not Due to Neuropathy, CTCAE


name: Lower Extremity Muscle Weakness, CTCAE Not Due to Neuropathy


name: Trunk Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 5 Ocular Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 4 Ocular Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 2 Trunk Muscle Weakness Not Due to Neuropathy, CTCAE


name: Facial Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 5 Pelvic Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 1 Ocular Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 2 Left-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 5 Whole Body and Generalized Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 4 Extraocular Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 2 Lower Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 1 Extraocular Muscle Weakness Not Due to Neuropathy, CTCAE


name: Whole Body and Generalized Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 4 Pelvic Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 3 Ocular Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 2 Right-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 3 Upper Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 4 Upper Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


name: Extraocular Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 5 Left-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 3 Trunk Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 5 Extraocular Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 3 Pelvic Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 1 Right-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 3 Extraocular Muscle Weakness Not Due to Neuropathy, CTCAE


name: Ocular Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 2 Upper Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


name: Upper Extremity Muscle Weakness, CTCAE Not Due to Neuropathy


name: Grade 1 Trunk Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 1 Whole Body and Generalized Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 5 Lower Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 5 Facial Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 4 Trunk Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 1 Facial Muscle Weakness Not Due to Neuropathy, CTCAE


name: Pelvic Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 3 Lower Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 2 Extraocular Muscle Weakness Not Due to Neuropathy, CTCAE


name: Left-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 2 Facial Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 3 Facial Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 1 Upper Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 2 Whole Body and Generalized Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 4 Facial Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 3 Left-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 1 Left-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 4 Lower Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 2 Pelvic Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 2 Ocular Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 5 Right-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


name: Grade 3 Right-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


Multiple Solitary Plasmacytoma of Bone

description: The presence of more than one plasmacytoma arising in the bone, concurrently or sequentially, in the absence of bone marrow involvement by plasma cell myeloma.


chlorocycloalkane

A chlorohydrocarbon that is any cycloalkane substituted by at least one chloro group.


monochlorocyclohexane

A chlorocyclohexane carrying a single chloro group.


chlorocyclohexane

Any chlorocycloalkane that is cyclohexane substituted by at least one chlorine group.


Disrupted Suture

description: The loss of tension or continuity of sutures.


A derivative of eugenol with methyl substituents at ring positions 3, 5 and 6.


squaric acid

A carbon oxoacid that consists of 1,2-diketocyclobut-3-ene bearing two enolic hydroxy substituents at positions 3 and 4.


A monovalent inorganic anion that consists of silicic acid in which one of the four OH groups has been deprotonated.


A trivalent inorganic anion obtained by removal of three protons from silicic acid.


A divalent inorganic anion obtained by removal of two protons from silicic acid.


ovarian microcystic stromal tumor

description: A benign, unilateral tumor that arises from the ovary and is characterized by the presence of conspicuous microcystic changes, cellular areas, and a fibrous stroma.


benign ovarian sex cord-stromal tumor

description: A sex cord-stromal tumor arising from the ovary, without metastatic potential.


ovarian fibrothecoma

description: A rare, benign, sex cord-stromal neoplasm, with a typically unilateral location in the ovary, characterized by mixed features of both fibroma and thecoma. Patients may be asymptomatic or may present with pelvic/abdominal pain and/or distension and, occasionally, with post-menopausal bleeding. Large tumors (>10cm) are often associated with pleural effusion and ascites (the Meigs syndrome triad).


prostate phyllodes tumor

description: An unusual, biphasic benign or malignant neoplasm that arises from the prostate gland. It is characterized by the presence of an epithelial glandular component and a proliferating stroma.


Borderline Vulvar Phyllodes Tumor

description: A rare borderline phyllodes tumor arising from the vulva.


benign prostate phyllodes tumor

description: A rare benign neoplasm that arises from the prostate gland and is characterized by the presence of hyperplastic glands and stroma that contains spindle-shaped cells.


Refractory Malignant Phyllodes Tumor

description: Malignant phyllodes tumor that is resistant to treatment.


name: Phyllodes Tumor of Anogenital Mammary-Type Glands

description: A rare phyllodes tumor that arises from mammary-like glands in the anogenital region.


Malignant Vulvar Phyllodes Tumor

description: A rare malignant phyllodes tumor arising from the vulva.


benign phyllodes tumor

description: A benign, circumscribed fibroepithelial neoplasm arising from the breast and rarely the prostate gland. It is characterized by the presence of epithelial structures which are arranged in clefts and by a hypercellular mesenchymal stroma which is organized in leaf-like structures. There is no evidence of cellular atypia or sarcomatous features.


malignant phyllodes tumor

description: A phyllodes tumor with sarcomatous stroma. The sarcomatous component is usually of the fibrosarcomatous type. Liposarcomatous, chondrosarcomatous, osteosarcomatous, or rhabdomyosarcomatous differentiation may also occur in the stroma. It may recur and metastasize following surgical resection. The lung and skeleton are the anatomic sites most frequently involved by metastases.


Benign Vulvar Phyllodes Tumor

description: A rare benign phyllodes tumor arising from the vulva.


Childhood Breast Phyllodes Tumor

description: A phyllodes tumor that arises from the breast and occurs during childhood.


Vulvar Phyllodes Tumor

description: A rare benign, borderline, or malignant phyllodes tumor arising from the vulva.


Borderline phyllodes tumor

description: A phyllodes tumor with morphologic characteristics which are intermediate between a benign and a malignant phyllodes tumor. The stromal sarcomatous changes are of low grade and are often reminiscent of low grade fibrosarcomas.


malignant prostate phyllodes tumor

description: An unusual malignant tumor that arises from the prostate gland. It is characterized by the presence of glandular elements and a cellular stroma that exhibits mitotic activity and nuclear atypia.


validamycins

Any of the inositol-derived beta-D-glucoside antibiotics produced by Streptomyces hygroscopicus.


validamycin B

A member of the class of validamycins that is validamycin A in which the pro-R hydrogen at the unsubstituted position of the cycloxexane ring has been replaced by a hydroxy group.


VALIDAMYCIN

A member of the class of validamycins that is (1R,2S,3S,4S,6R)-4-amino-6-(hydroxymethyl)cyclohexane-1,2,3-triol in which the hydroxy group at position 1 has been converted to its beta-D-glucoside and in which one of the hydrogens attached to the nitrogen is replaced by a (1R,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl group. It is the major validamycin produced by Streptomyces hygroscopicus.


name: megalencephalic leukoencephalopathy with subcortical cysts 4, remitting


name: paternal uniparental disomy of chromosome 7

description: Paternal uniparental disomy of chromosome 7 is an uniparental disomy of paternal origin that most likely do not have any phenotypic expression except from cases of homozygosity for a recessive disease mutation for which only father is a carrier (e.g., cystic fibrosis, congenital chloride diarrhea, sensorineural hearing loss).


name: Injury to stomach with open wound into cavity

description: Trauma to the stomach associated with a break in the tissue that extends into the abdominal cavity.


name: Parathyroid Carcinoma cM0 TNM Finding v8

description: No distant metastasis. (from AJCC 8th Ed.)


spindle cell neoplasm

description: A benign or malignant neoplasm characterized by the presence of neoplastic spindle cells.


ciliary body spindle cell melanoma

description: A spindle cell melanoma that involves the ciliary body.


spindle cell lipoma

description: A benign circumscribed tumor composed of spindled cells, adipocytes, and collagen bundles. There is no evidence of nuclear hyperchromasia or mitotic activity.


iris spindle cell melanoma

description: A spindle cell melanoma that involves the iris.


desmoplastic melanoma

description: A melanoma of the skin characterized by a proliferation of atypical spindled melanocytes in the dermis, in a background of abundant collagen. It usually presents as an amelanotic raised nodular lesion.


malignant spindle cell neoplasm

description: A malignant neoplasm characterized by the presence of atypical spindle cells.


spindle cell melanoma

description: A melanoma characterized by the presence of malignant spindle-shaped melanocytes.


spindle cell intraocular melanoma

description: A melanoma arising from the choroid, ciliary body, or the iris. It is characterized by the presence of spindle-shaped melanocytes.


name: Complex Endometrial Hyperplasia with Atypia

description: A hyperplasia characterized by excessive proliferation of endometrial cells, resulting in the formation of complex epithelial structures.  It is associated with cytologic atypia and an increased risk of endometrial adenocarcinoma.


name: Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor

description: A well differentiated neuroendocrine tumor that arises from the ampulla of Vater and the periampullary region.  It produces serotonin.


4-ethylphenyl sulfate

An aryl sulfate that is 4-ethylphenol in which the hydroxy group has been replaced by a sulfooxy group.


name: Quercetin 3-methyl ether 7-alpha-L-arabinofuranosyl-(1->6)-glucoside


First Relapse

description: The reemergence of a disorder as diagnosed by clinical and/or laboratory evidence following a single documented period of remission.


description: Evidence of opioid dependence with intoxication with perceptual disturbance.


gonococcal cystitis

description: An cystitis caused by infection with Neisseria gonorrhoeae.


acute gonococcal cystitis

description: Acute form of gonococcal cystitis.


A member of the class of azetidines that is propylazetidine substituted by a 3-pyridyl group position 2 and a 4-toluenesulfonamido group at position 3.


FGFR2IIIb Positive

description: An indication that FGFR2IIIb expression has been detected in a sample.


name: acetic acid [2-(1-acetyl-6-indolyl)-2-oxoethyl] ester


name: Proteinaceous Fluid in the Aqueous Humor

description: The aqueous humor contains a higher than normal amount of protein.


(S)-clenbuterol

The (S)-enantiomer of clenbuterol.


A pyridinium cation with a methyl substituent at the 1-position and a 4-(dihexadecylamino)styryl substituent at the 4-position.


A member of the class of  propanolamines that is propane with a hydroxy substituent at C-1 and an amino substituent at C-2, making it both a primary amine and a primary alcohol.


enaminone

A compound containing a conjugated system of an amine, an alkene and a ketone.


An alkylamine having isobutyl as the alkyl group. It has been isolated from Sambucus nigra (Elderberry).


A phenylalkylamine that is benzene in which one of the hydrogens is substituted by a 3-aminopentyl group.


(R)-dobutamine

The (R)-enantiomer of dobutamine.


7,8-diaminononanoic acid

An amino fatty acid carrying amino substituents at positions 7 and 8. Some of its isomers are naturally occurring intermediates of biotin synthesis, and targets of antimicrobial and herbicide development.


A primary aliphatic amine that is hexane substituted by an amino group at position 2.


coelimycin P1

An organosulfur heterocyclic compound that is 1,5-oxathiocane which has been substituted at the 2-pro-R, 3, 6, and 8 positions by oxo, acetamido,  5,6-dihydropyridin-2(1H)-ylidene, and  (2E)-but-2-enoyl groups, respectively, and which has been dehydrogenated to introduce a double bond at the 7-8 position. It was isolated from Streptomyces coelicolor M145 after genetically engineered increase of the metabolic flux and is the product of a polyketide biosynthetic gene cluster.


A 6-carbon primary aliphatic amine.


FM 4-64(2+)

A pyridinium cation with a 3-(triethylammonio)propyl substituent at the 1-position and a 6-[4-(dibutylamino)phenyl]hexa-1,3,5-trien-1-yl substituent at the 4-position.


PENTADECYLAMINE

An alkylamine that is pentadecane substituted by an amino group at position 1.


N-cyclohexyl-2-aminoethanesulfonic acid

An alkanesulfonic acid that is cyclohexanamine in which one of the amino hydrogens is substituted by a 2-sulfoethyl group. It is used as a buffer (pH range of 8.6-10.0) for studying pH-dependent processes in enzymology.


A primary amine of general formula RCH2CH2NH2 where R represents an aryl moiety.


enamine

An amine RNR'R'' where R has a double bond adjacent to the amine nitrogen.


A primary arylamine that is p-xylene substituted at the 2 and 5 positions by amino groups. It is formally a reduction product of 2,5-dimethyl-1,4-benzoquinonediimine.


5-AMINOVALERIC ACID

A delta-amino acid comprising pentanoic acid with an amino substituent at C-5; a methylene homologue of gamma-aminobutyric acid (GABA) that is a weak GABA agonist.


A pyridinium cation with a methyl substituent at the 1-position and a 4-(dimethylamino)styryl substituent at the 2-position.


(-)-echitovenine

An Aspidosperma alkaloid that is (5alpha,12beta,19alpha)-2,3-didehydroaspidospermidine which is substituted by a methoxycarbonyl group at position 3 and by an acetoxy group at position 20.


The (S)-enantiomer of 2-phenylpropylamine.


Quinuclidine in which a hydrogen atom at position 3 is substituted by a hydroxy group.


9-aminononanoic acid

A omega-amino fatty acid that is nonanoic acid substituted by an amino group at position 9.


2-aminohexadecanoic acid

An alpha-amino fatty acid of chain length C16.


benethamine

An aromatic amine that is 2-phenylethanamine in which one of the hydrogens attached to the amino group is substituted by a benzyl group.


(Z)-2-aminobutenoic acid

A 2,3-dehydroamino acid resulting from the formal elimination of water from the side-chain of threonine.


(S)-diethylpropion

The (S)-enantiomer of amfepramone.


(Z)-3-amino-2-methylacrylic acid

An alpha,beta-unsaturated monocarboxylic acid that is methacrylic acid (2-methylacrylic acid) in which the pro-Z hydrogen at the beta position has been replaced by an amino group.


naphthylamine

A primary arylamine that is naphthalene substituted by an amino group at unspecified position.


tripropylamine

A tertiary amine that is ammonia in which each hydrogen atom is substituted by a propyl group.


ROLICYCLIDINE

Pyrrolidine in which the hydrogen attached to the nitrogen is substituted by a 1-phenylcyclohex-1-yl group.


A primary aliphatic amine that is pentane substituted by an amino group at position 3. Metabolite observed in cancer metabolism.


N-methylcyclohexylamine

A secondary aliphatic amine having methyl and cyclohexyl as the two alkyl groups.


(+)-TRANYLCYPROMINE

A 2-phenylcyclopropan-1-amine that is the (1S,2R)-enantiomer of tranylcypromine.


An aminobiphenyl whose amino group is at C-4 and is hydroxylated at C-4'.


kitastatin 1

An 18-membered cyclodepsipeptide having a 3-amino-2-hydroxybenzoyl group attached to the amino terminus. It is isolated from an Alaskan Kitasatospora sp. and exhibits antineoplastic activity.


secondary amine

A compound formally derived from ammonia by replacing two hydrogen atoms by hydrocarbyl groups.


cyclopropylamine

A primary aliphatic amine that consists of cyclopropane bearing a single amino substituent.


A member of the class of 1,4-benzoquinones that is 1,4-benzoquinone in which the hydrogens at positions 2 and 5 have been replaced by aziridin-1-yl groups while the hydrogens at positions 3 and 6 have been replaced by (2-hydroxyethyl)amino groups.


N,N-dimethylbutylamine

A tertiary amine consisting of n-butane having a dimethylamino substituent at the 1-position.


bufotenine

A tertiary amine that consists of N,N-dimethyltryptamine bearing an additional hydroxy substituent at position 5.


indigoidine

A member of the class of pyridone that is a dimeric blue pigment biosynthesised from L-glutamine.


A racemate comprising equimolar amounts of (R)- and (S)-3,4-methylenedioxy-N-ethylamphetamine3,4-methylenedioxy-N-ethylamphetamine.


tridodecylamine

A tertiary amine consisting of three dodecyl groups attached to a central nitrogen.


A propanoate ester that is propyl propanoate substituted by a benzyl and phenyl group at position 1, a methyl group at position 2 and a dimethylamino group at position 3.


PAP

A glycol that is a derivative of glycerol in which one of the hydroxy groups is replaced by an anilino group.


beta-amino-fatty acid

A fatty acid with an amino substituent at position C-3; constituent of iturinic antibiotics.


primary arylamine

A primary amine formally derived from ammonia by replacing one hydrogen atom by an aryl group. R-NH2 where R is an aryl group.


A primary aliphatic amine that is ethane-1,2-diamine substituted by an isopropyl group at the N atom.


flupyradifurone

A tertiary amino compound that is ammonia in which the nitrogens have been replaced by (6-chloropyridin-3-yl)methyl, 2,2-difluoroethyl, and 5-oxo-2,5-dihydrofuran-3-yl groups, respectively. A nicotinic acetylcholine receptor (AChR) agonist, it is used as an insecticide to control sucking pests in a variety of crops.


aralkylamine

An alkylamine in which the alkyl group is substituted by an aromatic group.


4-aminoazobenzene-3,4'-disulfonic acid

A member of the class of azobenzenes that is azobenzene in which one of the phenyl groups is substituted at the para position by a sulfo group, while the other is substituted at a meta position by a sulfo group and at the para position by an amino group. The disodium salt is the biological stain 'fast yellow'.


PROPYLAMINE

A member of the class of  alkylamines that is propane substituted by an amino group at C-1.


An  aromatic ether that is the derivative of 2-phenylethylamine with methoxy substituents at the 3- and 4-positions. It is an alkaloid isolated from the Cactaceae family.


A primary amino compound that is propan-1-amine which carries a phenyl group at position 1.


isoamylamine

A primary aliphatic amine that is butan-1-amine carrying a methyl substituent at position 3.


name: 2-[4-[[4-(dimethylamino)phenyl]methylidene]-5-oxo-1-phenyl-3-pyrazolyl]acetic acid ethyl ester


Azobenzene substituted at each of the phenyl 4-positions by an amino group.


gallamine

A tertiary amine non-depolarising muscle relaxant whose structure comprises a core benzene molecule substituted at each of C-1, C-2 and C-3 by an N,N-diethyl-2-(ethylamino)ethoxy group.


dioctylamine

A secondary amine in which the two alkyl substituents are specified as octyl.


aminobiphenyl

Any member of the class of biphenyls in which the biphenyl skeleton is substituted by at least one amino group.


TERT-BUTYLAMINE

A primary aliphatic amine that is ethylamine substituted by two methyl groups at position 1.


levdobutamine

The (S)-enantiomer of dobutamine.


3-aminooctanoic acid

A beta-amino acid that is caprylic acid which is substituted by an amino group at position 3.


SYBR Green I

A benzothiazolium ion resulting from the methylation of the nitrogen of the benzothiazole group of N-[4-(1,3-benzothiazol-2-ylmethylene)-1-phenyl-1,4-dihydroquinolin-2-yl]-N',N'-dimethyl-N-propylpropane-1,3-diamine. A cationic unsymmetrical cyanine dye that binds to double-stranded DNA and is used as a nucleic acid stain in molecular biology.


nintedanib

A member of the class of oxindoles that is a kinase inhibitor used (in the form of its ethylsulfonate salt) for the treatment of idiopathic pulmonary fibrosis and cancer.


A 24-membered macrolide antibiotic isolated from the fermentation broth of Streptomyces sp.NK154183. It exhibits antifungal and antitumour activity against the human colon adenocarcinoma.


neticonazole

An enamine that is ethene which is substituted at positions 1, 1, and 2 by o-pentoxyphenyl, 1H-imidazol-1-yl, and methylthio groups, respectively (the E isomer). An inhibitor of P450-dependent C-14alpha-demethylation of lanosterol (preventing conversion to ergosterol and inhibiting cell wall synthesis in fungi), it is used in Japan (generally as the corresponding hydrochloride salt) as an antifungal drug for the treatment of superficial skin infections.


perquinoline A

A perquinoline that is 8-amino 20-N-butanoic acid.


The (R)-enantiomer of 2-phenylpropylamine.


BENZYLAMINE

A primary amine compound having benzyl as the N-substituent. It has been isolated from  Moringa oleifera (horseradish tree).


A ring assembly that is the 2-(2,4-dibromophenyl) derivative of 4-[1-(benzylamino)ethylidene]-5-methyl-2,4-dihydropyrazol-3-one.


malachite green isothiocyanate cation

The iminium cation of malachite green isothiocyanate.


A primary amine comprising an octane skeleton with amino substituents at carbon positions 1 and 8; and an aminomethyl substituent at position 5.


chloridazone-methyl-desphenyl

A pyridazinone that is pyridazin-3(2H)-one substituted by an amino group at position 5, a chloro group at position 4 and a methyl group at position 2. It is a metabolite of the herbicide chloridazone.jfuyklriltoil


methoxyphenamine

An amphetamine methylated on nitrogen and with the phenyl ring methoxylated at C-2. A beta-adrenergic receptor agonist, it is used as a bronchodilator.


A secondary aliphatic amine with two undecyl groups


(2R)-aminoheptanoic acid

An alpha-amino fatty acid that is heptanoic acid substituted by an amino group at position 2 (the 2R stereoisomer).


A C-nitro compound that is a stilbene derivative having an N-methyl,N-5-carboxypentylamino group at the 4-position and a nitro substituent at the 4'-position.


celesticetin

A lincosamide antibiotic produced in Streptomyces caelestis.


diethyl(propyl)amine

A tertiary amine that is propylamine in which the two amino hydrogens are replaced by ethyl groups.


secodine

A methyl ester that is 1H-indole substituted by a 3-methoxy-3-oxoprop-1-en-2-yl group at position 2 and a 2-(5-ethyl-3,4-dihydropyridin-1(2H)-yl)ethyl groups at position 3. It is a transient intermediate in the synthesis of indole alkaloids such as vindoline and vincadifformine.


N-methylbutylamine

A secondary aliphatic amine having methyl and n-butyl as the two alkyl groups.


METHOXYPHENAMINE HYDROCHLORIDE

The hydrochloride salt of methoxyphenamine, a beta-adrenergic receptor agonist that regulates norephinephrine and ephinephrinein concentrations.


bacillaene

A polyene antibiotic obtained from Bacillus subtilis 168 that is active against a broad spectrum of bacteria. It is notoriously unstable.


vibegron

A pyrrolopyrimidine obtained by formal condensation of the carboxy group of (6S)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylic acid with the amino group of (R)-[(2R,5S)-5-(4-aminobenzyl)pyrrolidin-2-yl](phenyl)methanol. It is a beta3-adrenergic receptor agonist currently in clinical development for the treatment of patients with overactive bladder.


(R)-fenpropidin

A 1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine that has R configuration.


perquinoline B

A perquinoline that is 8-amino 20-N-propanoic acid.


A derivative of aniline in which the hydrogen at position 3 has been substituted by fluorine. It is used as a pharmaceutical intermediate.


The N-(4-aminobutyl) derivative of 3-aminopropanal.


A primary aliphatic amine that is n-pentane in which a hydrogen of one of the methyl groups is replaced by an amino group. A water-soluble liquid with boiling point 104degreeC, it is a strong irritant.


p-Ts-L-Lys-Me

A methyl ketone that is L-lysine with an alpha-amine hydrogen substituted with a 4-methylbenzenesulfonamide (tosyl) group and a methyl group replacing the hydroxy of the carboxylic acid.


A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a 2-aminophenyl group at position 2.


alkylamine

Any primary amine in which the substituent attached to nitrogen is an alkyl group.


difenoxin

A piperidinemonocarboxylic acid that is 4-phenylpiperidine-4-carboxylic acid in which the hydrogen attached to the nitrogen atom is substituted by a 3-cyano-3,3-diphenylpropyl group.


An amphetamine that is propylbenzene substituted by a hydroxy group at position 1 and by an amino group at position 2 (the 1R,2S-stereoisomer). It is a plant alkaloid.


A phenylalkylamine that is propan-1-amine substituted by a phenyl group at position 2. It is classified as a doping agent by the World Anti-Doping Agency.


hesperadin

An oxindole that is indolin-2-one which is substituted at position 5 by an (ethylsulfonyl)nitrilo group and at position 2 by a methylidene group, which is itself substituted by a phenyl group and a [4-(piperidin-1-ylmethyl)phenyl]amino group. An Aurora B kinase inhibitor, it is used to inhibit chromosome alignment and segregation.


LUPANINE

The delta-lactam obtained by formal oxidation at the 2-position of sparteine. The major alkaloid from the seeds of Lupinus exaltatus, L. mexicanus and L. rotundiflorus, it is among the most important of the tetracyclic quinolizidine alkaloids.


(R)-clenbuterol

The (R)-enantiomer of clenbuterol.


tranylcypromine

A member of the class of cyclopropanes carrying amino and phenyl substituents at positions 1 and 2 respectively.


An acetylenic compound that is 2,2-tetramethyl-3-hexyn-1-amine in which both amino hydrogens have been replaced by methyl groups.


An aza-steroid that is 5beta-cholestane in which the carbon at position 25 is replaced by a nitrogen. It inhibits sitosterol-to-cholesterol conversion in Caenorhabditis elegans.


A primary aliphatic amine that is pentan-3-amine substituted by methyl groups at positions 2 and 4. Metabolite observed in cancer metabolism.


A monocarboxylic acid that is but-2-enoic acid in which one of the hydrogens at position 4 is substituted by a [(E)-(5-oxo-2-phenyl-1,3-oxazol-4(5H)-ylidene)methyl]amino moiety.


dimethylthiambutene

N,N-Dimethylbut-3-en-2-amine in which each of the hydrogens at position 4 is substituted by a 2-thienyl group. An opioid analgesic drug, it is controlled under the UN Single Convention on Narcotic Drugs (1961), but is used in veterinary medicine, particularly in Japan.


amino fatty acid

A fatty acid containing at least one amino substituent.


(Z)-3-aminoperacrylic acid

The peracid of (Z)-3-aminoacrylic acid where the acidic -OH group has been replaced by an -OOH group.


phenylalkylamine

An arylalkylamine in which the aryl group is phenyl.


OCTADECYLAMINE

An 18-carbon primary aliphatic amine.


An alkylamine that is pent-3-en-1-amine substituted by a methyl group ay position 4.


FM 1-43(2+)

A pyridinium cation with a 3-(triethylammonio)propyl substituent at the 1-position and a 4-(dibutylamino)styryl substituent at the 4-position.


R(-)amphetamine

A 1-phenylpropan-2-amine that has R configuration.


name: Ethanesulfonic acid, 2-(cyclohexylamino)-, monosodium salt


alpha-amino fatty acid

A fatty acid with an amino substituent at position C-2.


A primary aliphatic amine that is propan-1,2-diamine substituted by an isopropyl group at N(1) and a methyl group at position 2. Metabolite observed in cancer metabolism.


yanuthone M

A class I yanuthone that is yanuthone K in which the double bond at the terminal end of the farnesyl substituent has undergone hydration to afford the corresponding tertiary alcohol. Isolated from the filamentous fungus Aspergillus niger, it shows antifungal activity towards the pathogenic yeast Candida albicans (IC50 = 77.5 +-3.7 muM).


A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.


(Z)-dehydrotyrosine

A 2,3-dehydroamino acid resulting from the formal elimination of a molecule of hydrogen from the side-chain of tyrosine.


Disperse Blue 124

A monoazo compound consisting of diazene with a 5-nitrothiazol-2-yl group attached to one nitrogen and a substituted 4-aminophenyl group attached to the other; used as a dye standard for the assay of allergy-releasing dyes in textiles.


name: 5-[(4-methyl-1-piperidinyl)methyl]-1-[4-(1-pyrrolyl)-1,2,5-oxadiazol-3-yl]-4-triazolecarboxylic acid ethyl ester


omega-amino fatty acid

Any fatty acid n atoms long having an amino substituent at position n (omega).


(S)-fenpropidin

A 1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine that has S configuration.


The N-(3-aminopropyl) derivative of 4-aminobutanal.


BUTYLAMINE

A primary aliphatic amine that is butane substituted by an amino group at position 1.


FENPROPIDIN

A racemate comprising equimolar amounts of (R)- and (S)-fenpropidin. A systemic fungicide, it is used for the control of foliar diseases in cereals and sugar beet.


arylmethylamine

An aralkylamine consisting of methylamine in which one of the methyl hydrogens is replaced by any aromatic group.


A nitrile that is acrylonitrile in which the hydrogen attached to the same carbon as the cyano group has been replaced by an o-(trifluoromethyl)phenyl group, while the remaining hydrogens of the ethenyl group have been replaced by amino and (4-aminophenyl)sulfanyl groups. The configuration of the double bond is not specified. It is an inhibitor of MEK1 and MEK2.


A primary aliphatic amine that is butan-2-amine substituted by a methyl group at position 2. Metabolite observed in cancer metabolism.


butenafine

Trimethylamine in which hydrogen atoms attached to different methyl groups are substituted by 1-naphthyl and 4-tert-butylphenyl groups. It is an inhibitor of squalene epoxidase, an enzyme responsible for the creation of sterols needed in fungal cell membranes, and is used as its hydrochloride salt for treatment of dermatological fungal infections.


methyldopate

The ethyl ester of alpha-methyl-L-dopa.


An amino dicarboxylic acid that is 4-aminohepta-2,4-dienoic acid which is substituted at position 6 by an oxo group [the (2Z,4E) isomer].


triethylamine

A tertiary amine that is ammonia in which each hydrogen atom is substituted by an ethyl group.


PicoGreen

A cyanine dye that is 1-phenylquinoline which is substituted at position 2 by a bis[3-(dimethylamino)propyl]amino group and at position 4 by a (3-methyl-1,3-benzothiazol-3-ium-2-yl)methylene group. The counter ion is not stated. A fluorochrome that selectively binds double-stranded DNA and has characteristics similar to that of SYBR-Green I.


DIMETHYLADENINE

A tertiary amine that is adenine substituted at N-6 by geminal methyl groups.


name: N-[[4-(diethylamino)phenyl]methylideneamino]carbamic acid tert-butyl ester


LDS 751(1+)

A cationic C3 cyanine-type compound with 4-(dimethylamino)phenyl and 6-(dimethylamino)-1-ethylquinolinium-2-yl groups at either end.


8-aminooctanoic acid

An omega-amino fatty acid that is octanoic acid which carries an amino group at position 8.


A member of the class of bipyridines that is 2,2'-bipyridine in which the hydrogens situated para to the ring nitrogens have been replaced by methyl and 3-amino-2-methylbut-2-en-1-imino groups.


A phenylalkylamine that is benzene in which one of the hydrogens is substituted by a 4-aminobutyl group.


ALISIAQUINONE C

An organic heterohexacyclic compound that is isolated from New Caledonian deep water sponge and exhibits antiplasmodial properties.


12-AMINODODECANOIC ACID

An omega-amino fatty acid that is dodecanoic acid in which one of the terminal amino hydrogens has been replaced by an amino group.


2-aminooctanoic acid

An alpha-amino fatty acid that is caprylic acid which is substituted at position 2 by an amino group.


A phenylalanine derivative that is phenylalanine in which the amino group is substituted by a [(E)-{[(Z)-2-amino-1,2-dicyanoethenyl]imino}methyl]amino group. It is a chemical intermediate for nucleotide synthesis.


ISOPROPYLAMINE

A member of the class of  alkylamines that is propane carrying an amino group at position 2.


A primary arylamine that is aniline in which the hydrogens at the 2- and 5-positions are replaced by methyl groups. It is used in the manufacture of dyes and other chemicals.


chloridazone-desphenyl

A heteroaryl hydroxy compound that is pyridazin-3-ol substituted by an amino group at position 5 and a chloro group at position 4. It is a metabolite of the herbicide chloridazone.


A secondary aliphatic amine that is sec-butylamine substituted by a methyl group at the N atom. Metabolite observed in cancer metabolism.


A primary aliphatic amine that is 3-aminopropan-1-ol in which the hydroxy group is replaced by a (2-ethylhexyl)oxy group.


A tertiary amine consisting of 1,2,3,4-tetrahydroquinoline having an N-methyl substituent.


diphenoxylate

A piperidinecarboxylate ester that is the ethyl ester of difenoxin.


sec-butylamine

A primary aliphatic amine that is butane in which one hydrogen at position 2 is replaced by an amino group. A fumigant fungicide with a high potential for bioaccumulation, it is not approved for fungicidal use in the European Union.


2-aminoacrylic acid

A 2,3-dehydroamino acid that is alanine which has been dehydrogenated to introduce a double bond between positions 2 and 3.


CERATAMINE A

An organic heterobicyclic compound, which is imidazo[4,5-d]azepin-5(6H)-one substituted by a 3,5-dibromo-4-methoxybenzyl group at position 4, a methyl group at position 6 and a methylamino group at position 2. It is an antimitotic alkaloid isolated from the marine sponge Pseudoceratina.


A monomethoxybenzene that is dopamine in which the hydroxy group at position 4 is replaced by a methoxy group.


cyclohexylamine

A primary aliphatic amine consisting of cyclohexane carrying an amino substituent.


ETHYLAMINE

A two-carbon primary aliphatic amine.


sevadicin

A non-ribosomal tripeptide with antibacterial activity of sequence D-Phe-D-Ala-Trp synthesized by the bee pathogenic bacterium Paenibacillus larvae.


primary amine

A compound formally derived from ammonia by replacing one hydrogen atom by a hydrocarbyl group.


A derivative of aniline in which the hydrogen at position 2 has been substituted by fluorine. It is used as a pharmaceutical intermediate


alkylamines

Any amine formally derived from ammonia by replacing one, two or three hydrogen atoms by alkyl groups.


A dinitrile that is succinonitrile in which the methylene hydrogens at positions 2 and 3 are substituted by amino(phenylsulfanyl)methylidene groups. It acts as an inhibitor of MEK (mitogen activated protein kinase kinase).


eschscholtzidine

A heteropentacyclic isoquinoline alkaloid having a tertiary amino bridging group.


name: N-[1-[4-(4-bromophenyl)-2-thiazolyl]-4-piperidinyl]carbamic acid tert-butyl ester


A member of the class of chromenes that is 7,7-dimethyl-5-oxo-5,6,7,8-tetrahydrochromene carrying additional amino, cyano and 3-cyclohexen-1-yl substituents at positions 2, 3 and 4 respectively.


dehydrosecodine

A member of the class of indoles that is methyl 2-(1H-indol-2-yl)prop-2-enoate in which the indole moiety has been substituted at position 3 by a 2-(5-ethylpyridin-1(2H)-yl)ethyl group. An intermediate in the biosynthesis of aspidosperma and iboga alkaloids.


ravidomycin

A C-glycosylated naphthoisochromene derivative obtained from Streptomyces ravidus; exhibits antibiotic and anticancer properties.


L-phenylalaninol

An amino alcohol resulting from the formal reduction of the carboxy group of L-phenylalanine to the corresponding alcohol.


(7R,8S)-7,8-diaminononanoic acid

The isomer of 7,8-diaminononanoic acid having (R)- and (S)- configurations at C-7 and C-8, respectively; an intermediate in the biosynthetic pathway of biotin. As biotin is made exclusively in plants and microorganisms, both the chemical structure and biosynthetic enzymes of DAPA are targets for the development of herbicides and antimicrobial drugs.


The (R)-enantiomer of 1-phenylethanamine.


tertiary amine

A compound formally derived from ammonia by replacing three hydrogen atoms by hydrocarbyl groups.


non-syndromic syndactyly

description: A congenital condition characterized by webbing between the fingers and/or toes, joining the digits together. In rare cases, the joining of the fingers or toes may involve bony fusion between the digits. Common causes include Down Syndrome and hereditary syndactyly.


syndactyly type 5

description: Syndactyly type 5 (SD5) is a very rare congenital limb malformation characterized by postaxial syndactyly of hands and feet, associated with metacarpal and metatarsal fusion of fourth and fifth digits.


non-syndromic synpolydactyly

description: A synpolydactyly that is not part of a larger syndrome.


polysyndactyly 4

description: Polysyndactyly or PPD4 is a form of preaxial polydactyly of fingers, a limb malformation syndrome, characterized by the presence of a thumb showing the mildest degree of duplication, being broad, bifid or with radially deviated distal phalanx. Syndactyly of various degrees of third-and-fourth fingers is occasionally present.


syndactyly type 1

description: Syndactyly type 1 (SD1), also named zygodactyly in the past, is a distal limb malformation characterized by complete or partial webbing between the 3th and 4th fingers and/or the 2nd and 3rd toes.


name: mesoaxial synostotic syndactyly with phalangeal reduction

description: Mesoaxial synostotic syndactyly (MSSD) with phalangeal reduction is a novel and distinct form of non-syndromic syndactyly including complete syndactyly of the 3rd and 4th fingers with synostoses of the corresponding metacarpals and associated single phalanges, syndactyly of the 2nd and 3rd toes and 5th finger clinodactyly.


syndactyly type 6

description: Syndactyly type 6 is a rare, genetic, non-syndromic, congenital limb malformation characterized by unilateral fusion of second to fifth fingers, amalgamation of distal phalanges in a knot-like structure, and second- and third-toe fusion. Some individuals present only with webbing between second and third toes, without involvement of fingers.


syndactyly type 4

description: A very rare congenital distal limb malformation characterized by complete bilateral syndactyly (involving all digits 1 to 5).


syndactyly type 8

description: Syndactyly type 8 is a rare, genetic, non-syndromic, congenital limb malformation characterized by unilateral or bilateral fusion of the fourth and fifth metacarpals with no other associated abnomalities. Patients present shortened fourth and fifth metacarpals with excessive separation between their distal ends, resulting in marked ulnar deviation of the little finger and an inability to bring the fifth finger in parallel with the other fingers.


synpolydactyly type 2

description: Any non-syndromic synpolydactyly in which the cause of the disease is a mutation in the FBLN1 gene.


syndactyly type 3

description: Syndactyly type 3 (SD3) is a rare congenital distal limb malformation characterized by complete and bilateral syndactyly between the 4th and 5th fingers.


TRIDECANAL

A long-chain fatty aldehyde that is tridecane in which two hydrogens attached to a terminal carbon are replaced by an oxo group.


Malignant Neoplasm of Right Optic Nerve

description: Evidence of a malignant neoplasm of the right optic nerve.


name: N-[2-(propan-2-ylamino)-1,3-benzodioxol-2-yl]carbamic acid ethyl ester


DIVALPROEX SODIUM

A mixture of valproic acid and its sodium salt in a 1:1 molar ratio. It is used for the management and treatment of seizure disorders, mania, and prophylactic treatment of migraine headache.


(+)-epigallocatechin

A flavan-3,3',4',5,5',7-hexol that has (2S,3S)-configuration.


A steroid acid that is 23,24-bisnor-chol-4-en-22-oic acid bearing additional oxo and hydroxy substituent at positions 3 and 9 respectively.


name: Advanced Malignant Small Intestinal Neoplasm

description: A malignant small intestinal neoplasm that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Malignant neoplasm of small intestine, incl duodenum metastatic

description: A malignant small intestinal neoplasm that has spread from its original site of growth to another anatomic site.


name: Locally Advanced Small Intestinal Carcinoma

description: Small intestinal carcinoma that has spread to nearby tissues or lymph nodes.


name: Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma

description: A small intestinal small cell neuroendocrine carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Small intestine adenocarcinoma metastatic

description: An adenocarcinoma that arises from the small intestine and has metastasized to other anatomic sites.


name: Advanced Small Intestinal Neuroendocrine Carcinoma

description: A small intestinal neuroendocrine carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Locally Advanced Small Intestinal Adenocarcinoma

description: Small intestinal adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes.


name: Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma

description: A small intestinal large cell neuroendocrine carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


Small intestine carcinoma metastatic

description: A carcinoma that arises from the small intestine and it has metastasized to other anatomic sites.


name: Metastatic Small Intestinal Neuroendocrine Carcinoma

description: A small intestinal neuroendocrine carcinoma that has spread from its original site of growth to another anatomic site.


name: muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14


myopathy caused by variation in GMPPB

description: Any myopathy in which the cause of the disease is a variation in the GMPPB gene.


name: muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B14


name: autosomal recessive limb-girdle muscular dystrophy type 2T

description: Autosomal recessive limb-girdle muscular dystrophy type 2T (LGMD2T) is a form of limb-girdle muscular dystrophy, that can present from birth to early childhood, characterized by hypotonia, microcephaly, mild proximal muscle weakness (leading to delayed walking and difficulty climbing stairs), mild intellectual disability and epilepsy. Additional manifestations reported in some patients include cataracts, nystagmus, cardiomyopathy, and respiratory insufficiency.


name: COX deficiency, benign infantile mitochondrial myopathy

description: A cytochrome-c oxidase deficiency disease characterized by localization to tissues of the skeletal muscles.


glycolaldehyde triphosphate

A member of the class of aldehydes that is glycolaldehyde in which the hydroxy hydrogen has been replaced by a triphosphate group.


name: ENSAT Stage III Adrenal Cortical Carcinoma

description: Stage III includes: T3/T4, N0/N1, M0.  Tumor of any size that has spread to the fat outside the adrenal gland or into nearby organs or tissues and/or has spread to the regional lymph nodes. (ENSAT 7th Ed, 2009)


name: Adrenal Cortical Carcinoma by ENSAT Stage

description: A term that refers to the staging of adrenal cortical carcinoma according to the European Network for the Study of Adrenal Tumors (ENSAT).


name: ENSAT Stage I Adrenal Cortical Carcinoma

description: Stage I includes: T1, N0, M0.  Tumor 5 cm or less in greatest dimension. The tumor has not invaded the surrounding tissues or organs and has not spread to lymph nodes or distant organs or tissues.  (ENSAT 7th Ed, 2009)


name: ENSAT Stage II Adrenal Cortical Carcinoma

description: Stage II includes: T2, N0, M0. Tumor greater than 5 cm. The tumor has not invaded surrounding tissues or organs and has not spread to lymph nodes or distant organs or tissues. (ENSAT 7th Ed, 2009)


name: ENSAT Stage IV Adrenal Cortical Carcinoma

description: Stage IV includes: Any T, Any N, M1. Tumor of any size that involves distant organs such as liver, bone or brain. The tumor may or may not involve nearby organs, tissues or lymph nodes. (ENSAT 7th Ed, 2009)


pentaglycine

A pentapeptide comprised of five glycine residues.


name: Grade 1 Atrial Tachycardia or Paroxysmal Atrial Tachycardia, CTCAE


name: Open fracture of carpal bone, unspecified

description: A traumatic break in one or more of the carpal bones that  involves a break in the adjacent skin.


Closed fracture of carpal bone

description: A traumatic break in one or more of the carpal bones  that does not involve a break in the adjacent skin.


A 1,2-diacyl-sn-glycerol where butyryl and oleoyl are the 1- and 2-acyl groups respectively.


A 1,3-diglyceride in which the acyl groups at positions 1 and 3 are specified as palmitoyl and oleoyl respectively (the R-stereoisomer).


diacylglycerol 28:0

A diglyceride in which the two acyl groups contain a total of 28 carbons and 0 double bonds.


diacylglycerol 34:2

A diglyceride in which the two acyl groups contain a total of 34 carbons and 2 double bonds.


diacylglycerol 33:1

A diglyceride in which the two acyl groups contain a total of 33 carbons and 1 double bond.


A 1,2-diacyl-sn-glycerol where oleoyl and lauroyl are the 1- and 2-acyl groups respectively.


A 1,2-diacyl-sn-glycerol that has palmitoyl and tetradecanoyl as 1- and 2-acyl groups respectively.


A 2,3-diacyl-sn-glycerol that has oleoyl and lauroyl as the 2- and 3-acyl groups respectively.


A diacylglycerol 40:10 in which the acyl groups specified at positions 1 and 2 are (6Z,9Z,12Z,15Z)-octadecatetraenoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


A diacylglycerol 38:2 in which the acyl groups specified at positions 1 and 2 are (9Z,12Z)-octadecadienoyl and  icosanoyl respectively.


A 1-alkyl-2-acylglycerol that has S-configuration.


diacylglycerol 34:0

A diglyceride in which the two acyl groups contain a total of 34 carbons and 0 double bonds.


A diacylglycerol 40:5 in which the acyl groups specified are  icosanoyl and (5Z,8Z,11ZZ,14Z,17Z)-eicosapentaenoyl respectively,


A  1,2-diglyceride with lauroyl and oleoyl as the two acyl groups.


diacylglycerol 36:3

A diglyceride in which the two acyl groups contain a total of 36 carbons and 3 double bonds.


A 1,2-diglyceride with stearoyl and oleoyl as the acyl groups.


A 1,2-diacyl-sn-glycerol where oleoyl and linoleoyl are the 1- and 2-acyl groups respectively.


A 1,2-diacyl-sn-glycerol that has palmitoyl and palmitoleoyl as 1- and 2-acyl groups respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as palmitoyl and arachidonoyl respectively.


A 1,2-diacyl-sn-glycerol with palmitoyl as the 1-acyl group and oleoyl as the 2-acyl group.


A glycerolipid where R1 is an alkyl or an acyl group, R2 is an acyl chain and R3 can be an H, a phosphate or a phospholipid group.


diacylglycerol 40:7

A diglyceride in which the two acyl groups contain a total of 40 carbons and 7 double bonds.


diacylglycerol 36:6

A diglyceride in which the two acyl groups contain a total of 36 carbons and 6 double bonds.


A 1,2-diglyceride with acyl groups at positions 2 and 3 of the sn-glycerol.


A  2,3-diacyl-sn-glycerol where oleoyl and arachidonoyl form the 2- and 3-acyl groups respectively.


A 1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are specified as 12-hydroxy-(9Z)-octadecenoyl.


A 1,2-diacyl-sn-glycerol where oleoyl and decanoyl are the 1- and 2-acyl groups, respectively.


A 1,2-diacyl-sn-glycerol that has lauroyl and oleoyl as 1- and 2-acyl groups respectively.


diacylglycerol 33:2

A diglyceride in which the two acyl groups contain a total of 33 carbons and 2 double bonds.


dioleoylglycerol

A diglyceride in which both groups are oleoyl with their positions of acylation unspecified. Formula C39H72O5. For the structure shown, either R1 = H and R2 = oleoyl or R1 = oleoyl and R2 = H.


A 1,2-diacyl-sn-glycerol where oleoyl and stearoyl are the 1- and 2-acyl groups respectively.


A 1,2-diglyceride in which the acyl groups at positions 1 and 2 are specifed as stearoyl and arachidonoyl respectively.


diacylglycerol (18:1/18:2/0:0)

A 1,2-diglyceride in which the fatty acyl groups at positions 1 and 2 are specified as C18:1 and C18:2 respectively.


A 1,2-diacyl-sn-glycerol where oleoyl and arachidonoyl are the 1- and 2-acyl groups respectively.


dihexadecanoylglycerol

A diglyceride that is glycerol in which any two of the hydroxy groups have undergone formal esterification by condensation with hexadecanoic (palmitic) acid. Formula C35H68O5. For the structure shown, either R1 = H and R2 = hexadecanoyl or R1 = hexadecanoyl and R2 = H.


A 1,2-diglyceride in which the acyl groups at positions 1 and 2 are specified as (11Z)-octadecenoyl.


diacylglycerol (16:0/18:1/0:0)

A 1,2-diglyceride in which the fatty acyl groups at positions 1 and 2 are specified as C16:0 and C20:1 respectively.


A  1,2-diacyl-sn-glycerol where arachidonoyl and oleoyl form the 1- and 2-acyl groups respectively.


diacylglycerol 38:7

A diglyceride in which the two acyl groups contain a total of 38 carbons and 7 double bonds.


A 1,2-diglyceride with myristoyl and oleoyl as the two acyl groups.


diacylglycerol 36:1

A diglyceride  in which the two acyl groups contain a total of 36 carbons and 1 double bond.


A  1,2-diacyl-sn-glycerol where icosanoyl and oleoyl are the 1- and 2-acyl groups respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups positions 1 and 2 are specified as alpha-linolenoyl and icosanoyl (arachidoyl) respectively.


A galactoglycerolipid that is 1,2-diacyl-3-beta-D-galactosyl-sn-glycerol in which the galactosyl moiety is acylated at position 6.


diacylglycerol 32:1

A diglyceride in which the two acyl groups contain a total of 32 carbons and 1 double bond.


diacylglycerol (18:0/18:1/0:0)

A 1,2-diglyceride in which the fatty acyl groups at positions 1 and 2 are specified as C18:0 and C18:1 respectively.


A 1,2-diacyl-sn-glycerol that has myristoyl and palmitoyl as 1- and 2-acyl groups respectively.


A 1,3-diglyceride in which both acyl groups are specified as linoleoyl.


diacylglycerol 26:0

A diglyceride in which the two acyl groups contain a total of 26 carbons and 0 double bonds.


diacylglycerol (16:0/20:1/0:0)

A 1,2-diglyceride in which the fatty acyl groups at positions 1 and 2 are specified as C16:0 and C18:1 respectively.


diacylglycerol 40:1

A diglyceride in which the two acyl groups contain a total of 40 carbons and 1 double bond.


diacylglycerol 36:5

A diglyceride in which the two acyl groups contain a total of 36 carbons and 5 double bonds.


diacylglycerol 36:2

A diglyceride in which the two acyl groups contain a total of 36 carbons and 2 double bonds.


diacylglycerol 34:1

A diglyceride in which the two acyl groups contain a total of 34 carbons and 1 double bond.


A 1,3-diglyceride in which both acyl groups are specified as palmitoleoyl.


diacylglycerol 38:2

A diglyceride in which the two acyl groups contain a total of 38 carbons and 2 double bonds.


diacylglycerol (18:0/22:6/0:0)

A 1,2-diglyceride in which the fatty acyl groups at positions 1 and 2 are specified as C18:0 and C22:6 respectively.


A  1,2-diacyl-sn-glycerol that has myristoyl and oleoyl as 1- and 2-acyl groups respectively.


diacylglycerol 36:4

A diglyceride in which the two acyl groups contain a total of 36 carbons and 4 double bonds.


A 2,3-diacyl-sn-glycerol in which both acyl groups are specified as stearoyl (octadecanoyl).


A 1,2-diacyl-sn-glycerol with myristoyl and palmitoleoyl as 1- and 2-acyl groups respectively.


A 1,2-diglyceride where linoleoyl and oleoyl are the two acyl groups.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as 7Z,10Z,13Z,16Z-docosatetraenoyl.


A 1,2-diglyceride in which the 1- and 2-acyl groups are specified as oleoyl and palmitoyl respectively.


A 1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are specified as palmitoleoyl and stearoyl respectively.


dioctanoylglycerol

A diglyceride obtained by acylation of any two hydroxy groups of glycerol by octanoic acid. Formula C19H36O5. For the structure shown, either R1 = H and R2 = octanoyl or R1 = octanoyl and R2 = H.


diacylglycerol (18:0/20:3/0:0)

A 1,2-diglyceride in which the fatty acyl groups at positions 1 and 2 are specified as C18:0 and C20:3 respectively.


diacylglycerol 30:0

A diglyceride in which the two acyl groups contain a total of 30 carbons and 0 double bonds.


A 1,2-diacyl-sn-glycerol that has stearoyl and oleoyl as the 1- and 2-acyl groups respectively.


A 1-alkyl-2-acyl-sn-glycerol in which the alkyl and acyl groups are specified as palmityl (hexadecyl) and arachidonoyl respectively.


A 1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are specified as palmitoleoyl.


A 2,3-diacyl-sn-glycerol that has  oleoyl and myristoyl as 2- and 3-acyl groups respectively.


diacylglycerol 35:3

A diglyceride in which the two acyl groups contain a total of 35 carbons and 3 double bonds.


A diglyceride in which both groups are (10Z)-heptadecenoyl with their positions of acylation unspecified. For the structure shown, either R1 = H and R2 = (10Z)-heptadecenoyl or R1 = (10Z)-heptadecenoyl and R2 = H.


A 1,2-diacyl-sn-glycerol in which the acyl groups positions 1 and 2 are specified as alpha-linolenoyl and (11Z,14Z)-icosadienoyl respectively.


A diacylglycerol having two docosahexaenoyl chains at undefined sn positions


A 2,3-diacyl-sn-glycerol in which the 2- and 3-acyl groups are both specified as oleoyl.


A dibutyrin resulting from the condensation the secondary hydroxy group and one of the primary hydroxy groups of glycerol with butyric acid.


A diacylglycerol 40:0 in which the acyl groups at positions 1 and 2 are octadecanoyl and docosanoyl respectively.


A 1,2-diacyl-sn-glycerol where both acyl groups are specified as octadecanoyl.


diacylglycerol 40:0

A diglyceride in which the acyl groups  contain a total of 40 carbons and 0 double bonds.


1,2 ditetradecanoylglycerol

A 1,2-diglyceride  in which the acyl groups at positions 1 and 2 are specifed as tetradecanoyl.


A 2,3-diacyl-sn-glycerol that has oleoyl and stearoyl as the 2- and 3-acyl groups respectively.


A 1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are specified as capryl (decanoyl) and oleoyl (9Z-octadecenoyl) respectively.


diacylglycerol 34:3

A diglyceride in which the two acyl groups contain a total of 34 carbons and 3 double bonds.


diacylglycerol 36:0

A diglyceride in which the two acyl groups contain a total of 36 carbons and 0 double bonds.


diacylglycerol 32:2

A diglyceride in which the two acyl groups contain a total of 32 carbons and 2 double bonds.


A 2,3-diacyl-sn-glycerol in which both acyl groups are specified as palmitoyl (hexadecanoyl).


diacylglycerol 46:7

A diglyceride in which the two acyl groups contain a total of 46 carbons and 7 double bonds.


A 1-alkyl-2-acyl-sn-glycerol in which the alkyl and acyl groups are specified as palmityl (hexadecyl) and oleoyl respectively.


A diacylglycerol 38:0 in which the acyl groups specified at positions 1 and 2 are hexadecanoyl and docosanoyl respectively.


A 1,3-diglyceride in which the acyl groups at positions 1 and 3 are specified as oleoyl and linoleoyl respectively.


diacylglycerol 34:5

A diglyceride in which the two acyl groups contain a total of 34 carbons and 5 double bonds.


diacylglycerol 40:5

A diglyceride in which the acyl groups contain a total of 40 carbons and 5 double bonds.


A 1,2-diacyl-sn-glycerol where oleoyl and myristoyl are the 1- and 2-acyl groups respectively.


A 1,2-diacyl-sn-glycerol where alpha-linolenoyl and oleoyl form the 1- and 2-acyl groups respectively.


A 2,3-diacyl-sn-glycerol in which both the 2- and 3-acyl groups are specified as octanoyl.


A 1,3-diglyceride in which both acyl groups are specified as linolenoyl.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as palmitoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


dibutyrin

A diglyceride resulting from the formal condensation of any two of the hydroxy groups of glycerol with the carboxy groups of two molecules of butanoic acid (either R1 = H and R2 = butanoyl, or R1 = butanoyl and R2 = H). A 'closed class'.


diacylglycerol 38:5

A diglyceride in which the two acyl groups contain a total of 38 carbons and 5 double bonds.


diacylglycerol (18:1/20:4/0:0)

A 1,2-diglyceride in which the fatty acyl groups at positions 1 and 2 are specified as C18:1 and C20:4 respectively.


A 1,2-diacyl-sn-glycerol where linoleoyl and oleoyl form the 1- and 2-acyl groups respectively.


diacylglycerol (16:0/22:6/0:0)

A 1,2-diglyceride in which the fatty acyl groups at positions 1 and 2 are specified as C16:0 and C22:6 respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as oleoyl and gondoyl respectively.


A 1,2-diglyceride in which the acyl groups at positions 1 and 2 are specified as decanoyl and oleoyl respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as stearoyl and 7Z,10Z,13Z,16Z-docosatetraenoyl respectively.


A diacylglycerol where the acyl group at sn-1 or sn-3 is palmitoyl and the acyl group at position sn-2 is unkown.


diacylglycerol 38:9

A diglyceride in which the two acyl groups contain a total of 38 carbons and 9 double bonds.


diacylglycerol (18:1/0:0/18:1)

A 1,3-diglyceride in which both acyl groups contain 18 carbons and 1 double bond.


A 1,3-diglyceride in which the acyl groups at positions 1 and 3 are specified as oleoyl and palmitoyl respectively.


A 1,2-diglyceride with palmitoyl and oleoyl as the two acyl groups.


dipalmitoleoylglycerol

A diglyceride in which both groups are palmitoleoyl with their positions of acylation unspecified. For the structure shown, either R1 = H and R2 = palmitoleoyl or R1 = palmitoleoyl and R2 = H.


diacylglycerol (18:0/20:4/0:0)

A 1,2-diglyceride in which the fatty acyl groups at positions 1 and 2 are specified as C18:0 and C20:4 respectively.


A  2,3-diacyl-sn-glycerol where oleoyl and alpha-linolenoyl form the 2- and 3-acyl groups respectively.


A 1,2-diglyceride where arachidonoyl and oleoyl are the two acyl groups.


A 1,3-diglyceride in which the acyl groups at positions 1 and 3 are specified as oleoyl and palmitoyl respectively (the S-stereoisomer).


A 1,2-diacyl-sn-glycerol in which both the acyl groups are specified as hexadecadienoyl (the position of the two double bonds is unspecified).


diacetin

A diglyceride resulting from the formal condensation of any two of the hydroxy groups of glycerol with the carboxy groups of two molecules of acetic acid (either R1 = H and R2 = Ac, or R1 = Ac and R2 = H).


diacylglycerol 42:11

A diglyceride in which the two acyl groups contain a total of 42 carbons and 11 double bonds.


A 1,3-diglyceride in which the 1- and 3-acyl groups are specified as palmitoyl and stearoyl respectively (the R-enantiomer).


diacylglycerol 30:1

A  diglyceride in which the two acyl groups contain a total of 30 carbons and 1 double bonds.


diacylglycerol 41:5

A diglyceride in which the two acyl groups contain a total of 41 carbons and 5 double bonds.


diacylglycerol 28:2

A diglyceride in which the two acyl groups contain a total of 28 carbons and 2 double bonds.


A 1,2-diacyl-sn-glycerol in which the acyl groups positions 1 and 2 are specified as alpha-linolenoyl and (8Z,11Z,14Z)-icosatrienoyl respectively.


A 2,3-diacyl-sn-glycerol in which both acyl groups are specified as caproyl (hexanoyl).


A 1,2-diacyl-sn-glycerol in which both acyl groups are tetradecanoyl (myristoyl).


diacylglycerol 28:1

A diglyceride in which the two acyl groups contain a total of 28 carbons and 1 double bond.


diacylglycerol 38:6

A diglyceride in which the two acyl groups contain a total of 38 carbons and 6 double bonds.


A 1-alkyl-2-acyl-sn-glycerol in which the 1-alkyl substituent can be any alk-1-enyl group.


diacylglycerol 40:10

A diglyceride in which the acyl groups contain a total of 40 carbon atoms and 0 double bonds.


A 1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are specified as palmitoleoyl and linoleoyl respectively.


A 2,3-diacyl-sn-glycerol in which both acyl groups are specified as myristoyl (tetradecanoyl).


diacylglycerol 38:4

A diglyceride in which the two acyl groups contain a total of 38 carbons and 4 double bonds.


A 1,3-diglyceride obtained by the formal acylation of positions 1 and 3 of glycerol by hexadecanoic (palmitic) acid.


diacylglycerol 44:12

A diglyceride in which the two acyl groups contain a total of 44 carbons and 12 double bonds.


diacylglycerol 34:4

A diglyceride in which the two acyl groups contain a total of 34 carbons and 4 double bonds.


diacylglycerol 41:1

A diglyceride in which the two acyl groups contain a total of 41 carbons and 1 double bond.


diacylglycerol 30:2

A diglyceride in which the two acyl groups contain a total of 30 carbons and 2 double bonds.


A 1,3-diglyceride in which both acyl groups are specified as octanoyl.


diacylglycerol 42:10

A diglyceride in which the two acyl groups contain a total of 42 carbons and 10 double bonds.


A diacylglycerol 34:1 in which the acyl groups specified at positions 1 and 2 are (11Z)-octadecenoyl and hexadecanoyl respectively.


diacylglycerol (16:0/22:4/0:0)

A 1,2-diglyceride in which the fatty acyl groups at positions 1 and 2 are specified as C16:0 and C22:4 respectively.


A diacylglycerol 34:0 in which the acyl groups specified at positions 1 and 2 are hexadecanoyl and octadecanoyl respectively.


A 2,3-diacyl-sn-glycerol in which both acyl groups are specified as palmitoleoyl.


diacylglycerol 37:1

A diglyceride in which the two acyl groups contain a total of 37 carbons and 1 double bond.


A 1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are specified as palmitoyl and (11Z,14Z)-eicosadienoyl respectively.


diacylglycerol (18:0/22:5/0:0)

A 1,2-diglyceride in which the fatty acyl groups at positions 1 and 2 are specified as C18:0 and C22:5 respectively.


A 1,2-diacyl-sn-glycerol in which both acyl groups are specified as palmitoyl (hexadecanoyl).


A 1,3-diglyceride with both acyl groups specified as oleoyl.


diacylglycerol 40:8

A diglyceride in which the acyl groups contain a total of 40 carbons and 8 double bonds.


palmitoylacylglycerol

A diacylglycerol with an undefined acyl group at position sn-1 or sn-3 and a palmitoyl group at an undefined position.


diacylglycerol 40:4

A diglyceride in which the two acyl groups contain a total of 40 carbons and 4 double bonds.


A 1,2-diacyl-sn-glycerol in which the acyl groups positions 1 and 2 are specified as alpha-linolenoyl and (11Z)-icosenoyl respectively.


dipropionin

A diglyceride resulting from the formal condensation of any two of the hydroxy groups of glycerol with the carboxy groups of two molecules of propionic acid (either R1 = H and R2 = propanoyl, or R1 = propanoyl and R2 = H).


diacylglycerol 38:3

A diglyceride in which the two acyl groups contain a total of 38 carbons and 3 double bonds.


A 1,2-diglyceride in which the acyl groups at positions 1 and 2 are specified as (9Z)-hexadecenoyl.


A 1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are specified as oleoyl and alpha-linolenoyl respectively.


A 1,2-diacyl-sn-glycerol that has pentadecanoyl as 1- and 2-acyl groups.


A 1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are specified as palmitoyl and (7Z,10Z,13Z,16Z)-docosatetraenoyl  respectively.


A 1,2-diglyceride with linolenoyl and oleoyl as the two acyl groups.


A 2,3-diacyl-sn-glycerol in which both acyl groups are specified as linoleoyl.


A 1,2-diacyl-sn-glycerol in which both the acyl groups are specified as (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl.


diacylglycerol (16:0/20:4/0:0)

A 1,2-diglyceride in which the fatty acyl groups at positions 1 and 2 are specified as C16:0 and C20:4 respectively.


SLG

A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as stearoyl and linoleoyl respectively.


diacylglycerol 32:0

A diglyceride in which the two acyl groups contain a total of 32 carbons and 0 double bond.


diacylglycerol 38:0

A diglyceride in which the acyl groups contain a total of 38 carbons and 0 double bonds.


A 1,3-diglyceride with acyl groups at positions 1 and 3 of sn-glycerol.


A diacylglycerol 36:0 in which both acyl group contain 18 carbons.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as (9Z,12Z)-octadecadienoyl and octadecanoyl respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups positions 1 and 2 are specified as alpha-linolenoyl and (5Z,8Z,11Z)-icosatrienoyl respectively.


diacylglycerol 35:0

A diglyceride in which the two acyl groups contain a total of 35 carbons and 0 double bonds.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as oleoyl.


A 1,2-diglyceride obtained by the formal acylation of positions 1 and 2 of glycerol by hexadecanoic (palmitic) acid.


A 1,2-diacyl-sn-glycerol where octanoyl and oleoyl form the 1- and 2-acyl groups respectively.


diacylglycerol (18:0/22:4/0:0)

A 1,2-diglyceride in which the fatty acyl groups at positions 1 and 2 are specified as C18:0 and C22:4 respectively.


A 2,3-diacyl-sn-glycerol where oleoyl and linoleoyl form the 2- and 3-acyl groups respectively.


diacylglycerol 32:3

A diglyceride in which the two acyl groups contain a total of 32 carbons and 3 double bonds.


A 2,3-diacyl-sn-glycerol with oleoyl as 2-acyl group and palmitoyl as the 3-acyl group.


diacylglycerol 31:1

A diglyceride in which the two acyl groups contain a total of 31 carbons and 1 double bond.


diacylglycerol 38:1

A diglyceride in which the two acyl groups contain a total of 38 carbons and 1 double bond.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are both myristoleoyl groups.


DOG

1,2-diacyl-sn-glycerol in which both the 1- and 2-acyl groups are specified as octanoyl. Formula C19H36O5.


diacylglycerol 33:3

A diglyceride in which the two acyl groups contain a total of 33 carbons and 3 double bonds.


A 1-(alk-1-enyl)-2-acyl-sn-glycerol in which the alk-1-enyl group has Z geochemistry.


diacylglycerol 40:6

A diglyceride in which the two acyl groups contain a total of 40 carbons and 6 double bonds.


A diacylglycerol 34:0 in which one acyl group contains 18 carbons the other, 16 carbons


dilinoleoylglycerol

A diglyceride that is glycerol in which any two of the hydroxy groups have undergone formal esterification by condensation with linoleic acid ((Z,Z)-octadeca-9,12-dienoic acid). Formula C39H68O5. For the structure shown, either R1 = H and R2 = linoleoyl or R1 = linoleoyl and R2 = H.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as oleoyl and 7Z,10Z,13Z,16Z-docosatetraenoyl respectively.


A 1,2-diacyl-sn-glycerol in which both acyl groups are specified as linoleoyl.


A diacyl-sn-glycerol with palmitoyl as the 1-acyl group and oleoyl with its position of acylation unspecified. For the structure shown, either R1 = H and R2 = oleoyl or R1 = oleoyl and R2 = H.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as oleoyl and 4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl respectively.


A 1,3-diglyceride in which the acyl groups at positions 1 and 3 are specified as palmitoyl (hexadecanoyl) and linoleoyl respectively.


A 2,3-diacyl-sn-glycerol in which the acyl groups at positions 2 and 3 are specified as palmitoyl and oleoyl respectively.


diacylglycerol 40:3

A diglyceride in which the two acyl groups contain a total of 40 carbons and 3 double bonds.


diacylglycerol 35:1

A diglyceride in which the two acyl groups contain a total of 35 carbons and 1 double bond.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as icosanoyl (arachidoyl) and arachidonoyl respectively.


A 1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are specified as palmitoyl and (8Z,11Z,14Z-eicosatrienoyl respectively.


diacylglycerol (18:1/22:4/0:0)

A 1,2-diglyceride in which the fatty acyl groups at positions 1 and 2 are specified as C18:1 and C22:4 respectively.


diarachidonoylglycerol

A diacylglycerol having two arachidonoyl chains at undefined sn positions


A 1,3-diglyceride in which both acyl groups contain 18 carbons and 2 double bonds.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as oleoyl and 8Z,11Z,14Z-eicosatrienoyl respectively.


A beta-D-galactosyl-(1->4)-beta-D-glucosylceramide where the ceramide N-acyl group is specified as hexacosanoyl.


name: trichorhinophalangeal syndrome, type III

description: A trichorhinophalangeal syndrome caused by mutations in TRPS1 characterized by the presence of severe brachydactyly, due to short metacarpals, and severe short stature.


tricin 7-O-beta-D-glucoside

A glycosyloxyflavone that is 3',5'-di-O-methyltricetin (tricin) in which the phenolic hydrogen at position 7 has been replaced by a beta-D-glucopyranosyl group.


name: round cell sarcoma with EWSR1-NFATC2 gene fusion

description: A round cell sarcoma with EWSR1-non-ETS fusion that is characterized by the presence of EWSR1-NFATC2 gene fusion.


name: Other Specified Diabetes Mellitus with Mild Nonproliferative Diabetic Retinopathy without Macular Edema, Left Eye

description: Evidence of other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema in the left eye not specified elsewhere.


name: 2-[(2R,3R,6S)-2-(hydroxymethyl)-3-(1-oxopropylamino)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester


Cyst of nasal cavity

description: An epithelium-lined cyst in the nasal cavity.


name: autosomal dominant nonsyndromic hearing loss 65

description: Any autosomal dominant nonsyndromic deafness in which the cause of the disease is a mutation in the TBC1D24 gene.


Probable Acute COVID-19 Case

description: A presumed acute COVID-19 infection as evidenced by detection of SARS-CoV-2 by antigen test in a respiratory specimen, by meeting clinical criteria and epidemiological linkage criteria for COVID-19 with no confirmatory laboratory testing performed, or by a death certificate that lists COVID-19 disease or SARS-CoV-2 as an underlying cause of death or a significant condition contributing to death with no confirmatory laboratory evidence of SARS-CoV-2.


name: Pulmonary Thromboembolic Disease Associated with Post-Acute Sequelae of SARS-CoV-2 Infection

description: Intravascular migration of a venous embolus to the pulmonary arterial circulation, microvascular thrombosis in the pulmonary capillaries, or pulmonary artery thrombus in situ diagnosed by a positive pulmonary angiogram, an unequivocally positive helical CT scan, a high-probability ventilation-perfusion scan, or autopsy that started during probable or confirmed acute COVID-19 and persisted beyond four weeks after the initial diagnosis of COVID-19.


name: Post-Acute Cardiovascular Sequelae of COVID-19

description: Cardiovascular sequelae persisting weeks or months after SARS-CoV-2 infection.


name: Supraventricular Tachyarrhythmia Other than Atrial Fibrillation or Atrial Flutter Associated with Post-Acute Sequelae of SARS-CoV-2 Infection

description: Supraventricular tachycardia other than atrial fibrillation or atrial flutter in a patient without prior history of atrial tachyarrhythmias that started during probable or confirmed acute COVID-19 and persisted beyond four weeks after the initial diagnosis of COVID-19.


name: Ischemic Cardiomyopathy Associated with Post-Acute Sequelae of SARS-CoV-2 Infection

description: Reduced left ventricular function with less than 50% ejection fraction in a patient with history of suspected or confirmed myocardial ischemia or acute coronary syndrome (ACS) that started during probable or confirmed acute COVID-19 and persisted beyond four weeks after the initial diagnosis of COVID-19.


long COVID-19

description: A chronic disease triggered by acute COVID-19 infection that is characterized by persistent symptoms following the acute phase of the SARS-CoV-2 infection, which may include fatigue, coughing, dyspnea, clouding of mentation, sleep disturbances, exercise intolerance and autonomic symptoms including tachycardia upon mild exercise or standing, night sweats, temperature dysregulation, gastroparesis, constipation or loose stools, and peripheral vasoconstriction.


name: Atrial Flutter Associated with Post-Acute Sequelae of SARS-CoV-2 Infection

description: Atrial flutter in a patient without prior history of atrial tachyarrhythmias that started during probable or confirmed acute COVID-19 and persisted beyond four weeks after the initial diagnosis of COVID-19.


name: Symptomatic COVID-19 Infection Laboratory-Confirmed

description: An infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is symptomatic at the time of testing.


name: Pericarditis Associated with Post-Acute Sequelae of SARS-CoV-2 Infection

description: Pericarditis that started during probable or confirmed acute COVID-19 and persisted beyond four weeks after the initial diagnosis of COVID-19.


Confirmed Acute COVID-19 Case

description: An acute COVID-19 infection that is verified by detection of SARS-CoV-2 RNA in a clinical or autopsy specimen using a molecular amplification test (e.g., RT-PCR).


name: Pericardial Effusion Associated with Post-Acute Sequelae of SARS-CoV-2 Infection

description: Pericardial effusion that started during probable or confirmed acute COVID-19 and persisted beyond four weeks after the initial diagnosis of COVID-19.


name: Atrial Fibrillation Associated with Post-Acute Sequelae of SARS-CoV-2 Infection

description: Atrial fibrillation in a patient without prior history of atrial tachyarrhythmias that started during probable or confirmed acute COVID-19 and persisted beyond four weeks after the initial diagnosis of COVID-19.


Severe COVID-19 Infection

description: An infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) where the individual is hospitalized, requires respiratory support, and may also require additional organ support including vasopressor therapy, renal replacement therapy, or extracorporeal membrane oxygenation. (based on WHO COVID-19 Disease Severity 5, 6 and 7)


name: Asymptomatic COVID-19 Infection Laboratory-Confirmed

description: An infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is asymptomatic at the time of testing.


Middle East respiratory syndrome

description: A viral respiratory infection that is caused by the MERS coronavirus (MERS-CoV), which most often manifests with moderate to severe respiratory symptoms, including productive cough and shortness of breath, which can progress to pneumonia and acute respiratory distress syndrome.


name: Cardiac Structural Abnormalities Associated with Post-Acute Sequelae of SARS-CoV-2 Infection

description: Cardiac structural changes or abnormalities characterized by myocardial systolic dysfunction or myocardial edema or fibrosis on non-invasive cardiac imaging that started during probable or confirmed acute COVID-19 and persisted beyond four weeks after the initial diagnosis of COVID-19.


name: New-onset Heart Failure Associated with Post-Acute Sequelae of SARS-CoV-2 Infection

description: New onset of heart failure with a clinical syndrome of dyspnea, fatigue, fluid retention/peripheral edema that started during probable or confirmed acute COVID-19 and persisted beyond four weeks after the initial diagnosis of COVID-19.


Suspected Acute COVID-19 Case

description: A likely acute COVID-19 infection as evidenced by detection of specific antibody in serum, plasma, or whole blood, or detection of specific antigen by immunocytochemistry in an autopsy specimen.


name: Prior COVID-19 Infection With Residual Sequelae of Post-Acute COVID-19

description: A finding indicating that there is prior evidence of COVID-19 in an individual who has residual sequelae of post-acute COVID-19.


Moderate COVID-19 Infection

description: An infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) where the individual is hospitalized and may require oxygen therapy. (based on WHO COVID-19 Disease Severity 3 and 4)


name: Prior COVID-19 Infection Without Residual Sequelae of Post-Acute COVID-19

description: A finding indicating that there is prior evidence of COVID-19 in an individual who has no residual sequelae of post-acute COVID-19.


Mild COVID-19 Infection

description: An infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) where the individual is still ambulatory but may have limitation of their activities. (based on WHO COVID-19 Disease Severity 1 and 2)


name: Neurovascular Disorder Associated with Post-Acute Sequelae of SARS-CoV-2 Infection

description: A disorder of the nervous system related to a vascular etiology that started during probable or confirmed acute COVID-19 and persisted beyond four weeks after the initial diagnosis of COVID-19.


name: Deep Venous Thrombosis Associated with Post-Acute Sequelae of SARS-CoV-2 Infection

description: Formation of multiple thrombi in the large veins of the body, diagnosed with Doppler ultrasound, occurring most frequently in lower extremities or upper extremities, that started during probable or confirmed acute COVID-19 and persisted beyond four weeks after the initial diagnosis of COVID-19.


COVID Reinfection

description: A new, discrete episode of acute COVID-19 in an individual with a prior history of probable/confirmed COVID-19.


name: Non-Ischemic Cardiomyopathy Associated with Post-Acute Sequelae of SARS-CoV-2 Infection

description: Reduced left ventricular function with less than 50% ejection fraction but without evidence of myocardial ischemia that started during probable or confirmed acute COVID-19 and persisted beyond four weeks after the initial diagnosis of COVID-19.


Current Seasonal Coronavirus Infection

description: Seasonal coronavirus infection is evident at the time of testing.


Prior COVID-19 Infection

description: A finding indicating that there is prior evidence of COVID-19 in an individual who is no longer in the infectious period.


name: diabetes mellitus type 1 with hyperglycemia

description: Evidence of type 1 diabetes mellitus with hyperglycemia.


chromosome Y disorder

description: Chromosomal disorder in which chromosome Y is affected.


isochromosomy Yq

description: Isochromosomy Yq is a rare gonosomy anomaly with a variable phenotype including a female phenotype with sexual development delay, streak gonads, short stature and Turner syndrome features and male phenotype with infertility due to azoospermia.


spermatogenic failure, Y-linked, 2

description: A Y-linked genetic condition caused by mutation(s) in the USP9Y gene, encoding probable ubiquitin carboxyl-terminal hydrolase FAF-Y.  It is associated with male infertility secondary to nonobstructive azoospermia and hypospermatogenesis.


48,XYYY syndrome

description: 48,XYYY syndrome is a rare Y chromosome number anomaly that affects only males and is characterized by mild-moderate developmental delay (especially speech), normal to mild intellectual disability, large, irregular teeth with poor enamel, tall stature and acne. Radioulnar stenosis and clinodactyly have also been associated. Boys generally present normal genitalia, while hypogonadism and infertility is frequently reported in adult males.


partial chromosome Y deletion

description: Male sterility due to chromosome Y deletion is characterized by a severe deficiency of spermatogenesis. Chromosome Y deletions are a frequent genetic cause of male infertility.


ring chromosome Y

description: Ring chromosome Y is a rare chromosome Y structural anomaly, with a highly variable phenotype, mostly characterized by short stature, partial to total gonadal failure, sexual infantilism, genital anomalies (e.g. ambiguous genitalia, hypospadias, cryptorchidism), and azoospermia or oligozoospermia. Additional reported features include speech delay, obesity, and acanthosis nigricans. Gender dysphoria and comorbid bipolar disorder have also been observed.


49,XYYYY syndrome

description: 49,XYYYY is a rare Y chromosome number anomaly with a variable phenotype mainly characterized by moderate to severe intellectual disability, speech delay, hypotonia, and mild dysmorphic features, including facial asymmetry, hypertelorism, bilateral low set 'lop' ears, and micrognatia. Skeletal abnormalities (such as skull deformities, radioulnar synostosis, elbow flexion, clinodactyly, brachydactyly) and behavourial problems have also been associated with this condition. Genitalia are normal at birth, although hypogonadism and azoospermia has been reported in adults.


isochromosomy Yp

description: Isochromosomy Yp is a rare gonosome anomaly characterized by various clinical presentations including normal healthy fertile males, male phenotype with infertility, and males with ambiguous genitalia or incomplete masculinization.


name: Type 1 Diabetes Mellitus with Proliferative Diabetic Retinopathy with Traction Retinal Detachment Involving the Macula, Unspecified Eye

description: Evidence of type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula in an unspecified eye.


name: Pancreatic Well Differentiated Ductal Adenocarcinoma

description: A pancreatic ductal adenocarcinoma characterized by the presence of duct-like structures and medium-sized malignant glandular structures.


Stage M3 Pineoblastoma

description: Gross nodular seeding is detected in the spinal subarachnoid space. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)


name: Type 2 diabetes mellitus without complication

description: Evidence of type 2 diabetes mellitus without complications.


Grade 3 CPK Increased, CTCAE

description: >5 x ULN-10 x ULN


(R,R)-asenapine

A 5-chloro-2-methyl-2,3,3a,12b-tetrahydrodibenzo[2,3:6,7]oxepino[4,5-c]pyrrole in which both of the stereocentres have R configuration.


name: Grade 1 Pharynx Mucositis or Stomatitis by Functional or Symptomatic Classification, CTCAE


(3R,5S)-fluvastatin sodium

An organic sodium salt resulting from the replacement of the proton from the carboxy group of (3R,5S)-fluvastatin by a sodium ion.


(R)-warfarin sodium

An organic sodium salt having 2-oxo-3-[(1R)-3-oxo-1-phenylbutyl]-2H-1-benzopyran-4-olate as the counterion (the racemate is warfarin sodium, an anticoagulant drug and rodenticide).


TABERSONINE

A monoterpenoid indole alkaloid with cytotoxic activity.


Childhood Cutaneous Melanoma

description: A rare melanoma of the skin that occurs during childhood.


name: Grade 4 Trachea Obstruction and Stenosis, CTCAE


Supraventricular Extrasystoles, CTCAE

description: An adverse event characterized by premature atrial contractions of the heart caused by signals originating from ectopic atrial sites or the atrioventricular node.


name: Grade 3 Supraventricular Extrasystoles, CTCAE


name: Grade 4 Supraventricular Extrasystoles, CTCAE


name: Grade 2 Supraventricular Extrasystoles, CTCAE


name: Grade 5 Supraventricular Extrasystoles, CTCAE


name: Grade 1 Supraventricular Extrasystoles, CTCAE


name: Grade 4 Other Musculoskeletal and Soft Tissue, CTCAE


name: Hepatitis B Virus Core Antibody Positive

description: An indication that antibodies that recognize a hepatitis B virus core protein have been detected in a sample.


N-acetyl-D-galactosaminic acid

A carbohydrate acid derivative comprising D-galactonic acid having the 2-hydroxy group replaced by acetamido.


Penile Cancer pT1a TNM Finding v7

description: Penile cancer with tumor invading subepithelial connective tissue without lymph vascular invasion and is not poorly differentiated (i.e., grade 3-4). (from AJCC 7th Ed.)


A 2-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as (11R)-hydroxy-(5Z,8Z,12E,14Z)-icosatetraenoyl.


skin sensitivity to sun

description: The response of human skin to sun exposure.


A chiral mycolic acid analogue comprising 3-hydroxypropanoic acid having a tetracosanyl group at position 2 and a further long-chain alkyl group containing cyclopropyl and methoxy functions attached at position 3.


acromelanosis

description: Acromelanosis is a congenital hyperpigmentation of the skin usually located on the acral areas of the fingers and toes. It is mostly observed in newborns or during the first years of life.


name: temperature-sensitive oculocutaneous albinism type 1

description: Type 1 temperature sensitive oculocutaneous albinism (OCA1-TS) is an extremely rare form of OCA1 characterized by the production of temperature sensitive tyrosinase proteins leading to dark hair on the legs, arms and chest (cooler body areas) and white hair on the scalp, axilla and pubic area (warmer body areas).


name: hyperpigmentation, progressive cribriform and zosteriform